Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Biologically active precursor

Damavaricins C (40) and D (41) are biologically active precursors of the streptovaricins and were isolated from the culture broth of a mutant of Nocardia mediterranei [86]. Damavaricin C (40) could be also obtained by... [Pg.63]

Thromboxane production has been detected in several inflammatory conditions in inflamed joints such as urate arthritis [343] and rheumatoid arthritis [92] in carageenin induced pleurisy [91] and in burns [93,94,344]. The involvement of thromboxanes in burns has attracted particular attention. TXB2 has been demonstrated both in burn blister fluid and in lymph from the scalded limb [93,344] as well as in burned tissue [94] and the formation of the biologically active precursor, TXA 2, has been postulated as one factor responsible for the progressive dermal ischemia seen after burn injury, which may lead to extensive skin necrosis [94,344], The effects of three inhibitors of thromboxane biosynthesis on dermal ischemia were studied [345]. All compounds were found to increase dermal perfusion after scalding injury compared to untreated animals, which supports the theory of the deleterious influence of TXA2 upon dermal circulation in burned tissues. [Pg.76]

The second application of the CFTI approach described here involves calculations of the free energy differences between conformers of the linear form of the opioid pentapeptide DPDPE in aqueous solution [9, 10]. DPDPE (Tyr-D-Pen-Gly-Phe-D-Pen, where D-Pen is the D isomer of /3,/3-dimethylcysteine) and other opioids are an interesting class of biologically active peptides which exhibit a strong correlation between conformation and affinity and selectivity for different receptors. The cyclic form of DPDPE contains a disulfide bond constraint, and is a highly specific S opioid [llj. Our simulations provide information on the cost of pre-organizing the linear peptide from its stable solution structure to a cyclic-like precursor for disulfide bond formation. Such... [Pg.164]

Biosynthesis. Two closely related genes encode the three mammalian tachykinins. The preprotachykinin A gene encodes both substance P and substance K, while the preprotachykinin B gene encodes neuromedin K (45—47). The active sequences are flanked by the usual double-basic amino acid residues, and the carboxy-terrninal amino acid is a glycine residue which is decarboxylated to an amide. As with most neuropeptide precursors, intermediates in peptide processing can be detected, but their biological activities are not clear (ca 1994). [Pg.202]

The Group III peptides come from the 256-amino acid precursor, pro-dynorphin [88402-55-5] (pro-enkephalin B). This group contains dynorphin A [80448-90-4] and B [85006-82-2] as weU as a-neoendorphin [77739-20-9] (Fig. 2), all of which can be further cleaved to form biologically active iatermediates, eg, dynorphin A g and P-neoendorphin [77739-21-0] (a-neoendorphin ) (28). The longer of these peptides are relatively basic because of the number of Lys and Arg residues. [Pg.446]

Many carotenoids function in humans as vitamin A precursors however, not all carotenoids have provitamin A activity (Table 3). Of the biologically active carotenoids, -carotene has the greatest activity. Despite the fact that theoretically one molecule of -carotene is a biological source of two molecules of vitamin A, this relationship is not observed and 6 p.g -carotene is equivalent to 1 p. vitamin A. Although -carotene and vitamin A have complementary activities, they caimot totally replace each other. Because the conversion of -carotene to vitamin A is highly regulated, toxic quantities of vitamin A cannot accumulate and -carotene can be considered as a safe form of vitamin A (8). [Pg.103]

The discovery that vitamin was metabolized to biologically active derivatives led to a significant effort to prepare 25-hydroxy vitamin and, subsequendy, the 1 a-hydroxy and 1,25 dihydroxy derivatives. Initial attempts centered around modification of steroidal precursors, which were then converted to the D derivatives by conventional means. [Pg.135]

Pha.rma.ceutica.ls. Neopentanoic acid derivatives are widely used in the preparation of pharmaceuticals, eg, as a means of introducing the tert-huty group into a molecule. More frequendy, however, derivatives have been prepared that exploit the enhanced hydrolytic stabiUty of the neopentanoate group. Eor example, when salmon calcitonin is treated with N-hydroxysuccinimide pivalate [42014-50-6], the resulting derivative retains the biological activity of the precursor, but gives an extended duration of activity (51). [Pg.104]

The chromaffin cells of the adrenal medulla may be considered to be modified sympathetic neurons that are able to synthesize E from NE by /V-methylation. In this case the amine is Hberated into the circulation, where it exerts effects similar to those of NE in addition, E exhibits effects different from those of NE, such as relaxation of lung muscle (hence its use in asthma). Small amounts of E are also found in the central nervous system, particularly in the brain stem where it may be involved in blood pressure regulation. DA, the precursor of NE, has biological activity in peripheral tissues such as the kidney, and serves as a neurotransmitter in several important pathways in the brain (1,2). [Pg.354]

Mammals can add additional double bonds to unsaturated fatty acids in their diets. Their ability to make arachidonic acid from linoleic acid is one example (Figure 25.15). This fatty acid is the precursor for prostaglandins and other biologically active derivatives such as leukotrienes. Synthesis involves formation of a linoleoyl ester of CoA from dietary linoleic acid, followed by introduction of a double bond at the 6-position. The triply unsaturated product is then elongated (by malonyl-CoA with a decarboxylation step) to yield a 20-carbon fatty acid with double bonds at the 8-, 11-, and 14-positions. A second desaturation reaction at the 5-position followed by an acyl-CoA synthetase reaction (Chapter 24) liberates the product, a 20-carbon fatty acid with double bonds at the 5-, 8-, IT, and ITpositions. [Pg.816]

Amino acid separations represent another specific application of the technology. Amino acids are important synthesis precursors - in particular for pharmaceuticals -such as, for example, D-phenylglycine or D-parahydroxyphenylglycine in the preparation of semisynthetic penicillins. They are also used for other chiral fine chemicals and for incorporation into modified biologically active peptides. Since the unnatural amino acids cannot be obtained by fermentation or from natural sources, they must be prepared by conventional synthesis followed by racemate resolution, by asymmetric synthesis, or by biotransformation of chiral or prochiral precursors. Thus, amino acids represent an important class of compounds that can benefit from more efficient separations technology. [Pg.217]

LPA, i.e. monoacyl-glycerol-3-phosphate, can be formed and degraded by multiple metabolic pathways (Fig. 1). Depending on the precursor molecule and respective pathway, the fatty acid chain in LPA differs in length, degree of saturation and position (sn-1 or sn-2), which has an influence on biological activity. LPA... [Pg.712]

Summary term for a number of steroid hormones and their precursors with differentiation-inducing activity in many tissues. As regards bone, three components are relevant cholecalciferol ( vitamin D ) 25-hydroxyvi-taminD3 (calcidiol) and 1,25-dihydroxy vitamin D3 (calcitriol). The latter is the biologically active form and increases both intestinal calcium absoiption and bone resorption. Vitamin D preparations are widely used for the treatment of osteoporosis. Daily supplementation with vitamin D reduces bone loss in postmenopausal women and hip fractures in elderly subjects. [Pg.1294]

Although non-exhaustive, this review shows that a large variety of new difunc-tionalized mixed phosphorus and sulfur molecular structures have been described during the last ten years. It also demonstrates that such compounds are powerful synthetic tools or building blocks and, in some cases, molecules (or precursors of more complex molecules) with potential biological activities. [Pg.193]


See other pages where Biologically active precursor is mentioned: [Pg.165]    [Pg.63]    [Pg.45]    [Pg.738]    [Pg.283]    [Pg.294]    [Pg.304]    [Pg.461]    [Pg.165]    [Pg.63]    [Pg.45]    [Pg.738]    [Pg.283]    [Pg.294]    [Pg.304]    [Pg.461]    [Pg.324]    [Pg.200]    [Pg.539]    [Pg.501]    [Pg.500]    [Pg.103]    [Pg.123]    [Pg.72]    [Pg.10]    [Pg.684]    [Pg.606]    [Pg.65]    [Pg.401]    [Pg.753]    [Pg.908]    [Pg.1147]    [Pg.1268]    [Pg.174]    [Pg.235]    [Pg.270]    [Pg.143]    [Pg.409]    [Pg.34]    [Pg.189]    [Pg.233]   
See also in sourсe #XX -- [ Pg.23 , Pg.63 ]

See also in sourсe #XX -- [ Pg.63 ]




SEARCH



Biogenetic precursors Biological activity

Biologically active precursor of damavaricin

© 2024 chempedia.info